{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:02:27Z","timestamp":1788580947315,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.atherosclerosis.2006.09.005","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T20:02:11Z","timestamp":1161201731000},"page":"153-159","source":"Crossref","is-referenced-by-count":50,"title":["Impact of increased plasma serotonin levels and carotid atherosclerosis on vascular dementia"],"prefix":"10.1016","volume":"195","author":[{"given":"Yoshiyuki","family":"Ban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunenori","family":"Idei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Katagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1749-6632.2002.tb04795.x","article-title":"Vascular dementia in Japan","volume":"977","author":"Yanagihara","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.metabol.2003.11.020","article-title":"Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia","volume":"53","author":"Watanabe","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1532-5415.2005.53204.x","article-title":"High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia","volume":"53","author":"Yamamoto","year":"2005","journal-title":"J Am Geriatric Soc"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib4","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/j.1532-5415.2005.53524.x","article-title":"Relation of serum insulin-like growth factor-1 levels to Alzheimer's disease and vascular dementia","volume":"53","author":"Watanabe","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000077812","article-title":"Influence of insulin-like growth factor-1 and hepatocyte growth factor on carotid atherosclerosis and cognitive function in the elderly","volume":"18","author":"Watanabe","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.100.5.483","article-title":"Serotonin is associated with coronary artery disease and cardiac events","volume":"100","author":"Vikenes","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1517\/13543784.13.7.865","article-title":"Sarpogrelate: cardiovascular and renal clinical potential","volume":"13","author":"Doggrell","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib8","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/01.CIR.90.4.1919","article-title":"Mitogenic effect of serotonin on vascular endothelial cells","volume":"90","author":"Pakala","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib9","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/01.CIR.96.7.2280","article-title":"Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation","volume":"96","author":"Pakala","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/147323000403200209","article-title":"Effect of the serotonin blocker sarpogrelate on circulating interleukin-18 levels in patients with diabetes and arteriosclerosis obliterans","volume":"32","author":"Yamakawa","year":"2004","journal-title":"J Int Med Res"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib11","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.CIR.103.10.1440","article-title":"Lysophosphatidylcholine and reactive oxygen species mediate the synergistic effect of mildly oxidized LDL with serotonin on vascular smooth muscle cell proliferation","volume":"103","author":"Watanabe","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0021-9150(00)00526-8","article-title":"Lipid peroxidation product 4-hydroxy-2-nonenal acts synergistically with serotonin in inducing vascular smooth muscle cell proliferation","volume":"155","author":"Watanabe","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0022-2143(99)90107-5","article-title":"Synergy between thrombin and serotonin in inducing vascular smooth muscle cell proliferation","volume":"134","author":"Pakala","year":"1999","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/00004872-200104000-00010","article-title":"Angiotensin II and serotonin potentiate endothelin-1-induced vascular smooth muscle cell proliferation","volume":"19","author":"Watanabe","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib15","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/00004872-200112000-00012","article-title":"Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation","volume":"19","author":"Watanabe","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000051065","article-title":"Monocyte chemotactic protein 1 amplifies serotonin-induced vascular smooth muscle cell proliferation","volume":"38","author":"Watanabe","year":"2001","journal-title":"J Vasc Res"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.atherosclerosis.2005.08.007","article-title":"Serotonin acts as an up-regulator of acyl-coenzyme A: cholesterol acyltransferase-1 in human monocyte-macrophages","volume":"186","author":"Suguro","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib18","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1161\/01.CIR.102.20.2522","article-title":"Serotonin increases interleukin-6 synthesis in human vascular smooth muscle cells","volume":"102","author":"Ito","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib20","doi-asserted-by":"crossref","unstructured":"Suguro T, Watanabe T, Kodate S, et al. Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension. Am J Hypertens 2006, in press.","DOI":"10.1016\/j.amjhyper.2006.08.001"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ghir.2005.09.001","article-title":"The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis","volume":"15","author":"Arwert","year":"2005","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1253\/circj.66.216","article-title":"Circulating hepatocyte growth factor as a diagnostic marker of thrombus formation in patients with cerebral infarction","volume":"66","author":"Matsumori","year":"2002","journal-title":"Circ J"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1474-4422(05)70099-5","article-title":"Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis","volume":"4","author":"Kuo","year":"2005","journal-title":"Lancet Neurol"},{"issue":"Suppl. 2","key":"10.1016\/j.atherosclerosis.2006.09.005_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000089361","article-title":"Vascular dementia prevention: a risk factor analysis","volume":"20","author":"Roman","year":"2005","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0165-0173(91)90009-W","article-title":"Serotonergic innervation of the cerebral vasculature: relevance to migraine and ischaemia","volume":"16","author":"Bonvento","year":"1991","journal-title":"Brain Res"},{"issue":"Suppl. 3","key":"10.1016\/j.atherosclerosis.2006.09.005_bib26","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/00005344-199000163-00005","article-title":"Serotonin 5-HT2 receptors and brain circulation","volume":"16","author":"Wiernsperger","year":"1990","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib27","first-page":"196","article-title":"Intact brain serotonin system in vascular dementia","volume":"7","author":"Hansson","year":"1996","journal-title":"Dementia"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib28","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/01.STR.23.6.870","article-title":"Serotonin release into plasma during common carotid artery thrombosis in rats","volume":"23","author":"Wester","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib29","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.STR.23.11.1595","article-title":"Ischemia-induced extracellular release of serotonin plays a role in CA1 neuronal cell death in rats","volume":"23","author":"Globus","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(92)90221-T","article-title":"Ketanserin reduces neuronal calcium accumulation and cell death in the hippocampus of the Mongolian gerbil after transient forebrain ischemia","volume":"578","author":"Klisch","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/07853890008998828","article-title":"Role of serotonin in memory impairment","volume":"32","author":"Buhot","year":"2000","journal-title":"Ann Med"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1021800822997","article-title":"Involvement of 5-HT (2A\/2B\/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism?","volume":"22","author":"Meneses","year":"2002","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1017\/S1041610200006645","article-title":"Serotonin 5-HT2A receptor binding in platelets from patients with Alzheimer's disease or vascular dementia","volume":"12","author":"Spigset","year":"2000","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.RES.58.1.58","article-title":"Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation","volume":"58","author":"Benedict","year":"1986","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJM199402243300802","article-title":"Local effect of serotonin released during coronary angioplasty","volume":"330","author":"Golino","year":"1994","journal-title":"New Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib36","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0002-9149(99)00564-0","article-title":"Intracoronary serotonin release after high-pressure coronary stenting","volume":"84","author":"Leosco","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0021-9150(97)00077-4","article-title":"Serotonin (5-hydroxytryptamine, 5-HT) enhances migration of rat aortic smooth muscle cell through 5-HT2 receptors","volume":"132","author":"Tamura","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib38","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0022-3565(24)35225-5","article-title":"Mechanisms of 5-hydroxytryptamine2A receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle","volume":"291","author":"Banes","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib39","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/j.1476-5381.1996.tb16732.x","article-title":"Characterization of 5-hyroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats","volume":"117","author":"Nishimura","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2006.09.005_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0952-3278(98)90047-3","article-title":"Effective long-term inhibition of thromboxane production but not of serotonin release in patients with coronary heart disease by 30mg\/d acetylsalicylic acid dosage","volume":"59","author":"Gajdos","year":"1998","journal-title":"Prostaglandins Leukot Essent Fatty Acids"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191500600551X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191500600551X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T16:20:15Z","timestamp":1736612415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191500600551X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S002191500600551X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.09.005","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}